Literature DB >> 35688155

Isoflurane inhibition of endocytosis is an anesthetic mechanism of action.

Sangwook Jung1, Pavel I Zimin2, Christian B Woods1, Ernst-Bernhard Kayser1, Dominik Haddad3, Colleen R Reczek4, Ken Nakamura5, Jan-Marino Ramirez6, Margaret M Sedensky2, Philip G Morgan7.   

Abstract

The mechanisms of volatile anesthetic action remain among the most perplexing mysteries of medicine. Across phylogeny, volatile anesthetics selectively inhibit mitochondrial complex I, and they also depress presynaptic excitatory signaling. To explore how these effects are linked, we studied isoflurane effects on presynaptic vesicle cycling and ATP levels in hippocampal cultured neurons from wild-type and complex I mutant (Ndufs4(KO)) mice. To bypass complex I, we measured isoflurane effects on anesthetic sensitivity in mice expressing NADH dehydrogenase (NDi1). Endocytosis in physiologic concentrations of glucose was delayed by effective behavioral concentrations of isoflurane in both wild-type (τ [unexposed] 44.8 ± 24.2 s; τ [exposed] 116.1 ± 28.1 s; p < 0.01) and Ndufs4(KO) cultures (τ [unexposed] 67.6 ± 16.0 s; τ [exposed] 128.4 ± 42.9 s; p = 0.028). Increasing glucose, to enhance glycolysis and increase ATP production, led to maintenance of both ATP levels and endocytosis (τ [unexposed] 28.0 ± 14.4; τ [exposed] 38.2 ± 5.7; reducing glucose worsened ATP levels and depressed endocytosis (τ [unexposed] 85.4 ± 69.3; τ [exposed] > 1,000; p < 0.001). The block in recycling occurred at the level of reuptake of synaptic vesicles into the presynaptic cell. Expression of NDi1 in wild-type mice caused behavioral resistance to isoflurane for tail clamp response (EC50 Ndi1(-) 1.27% ± 0.14%; Ndi1(+) 1.55% ± 0.13%) and halothane (EC50 Ndi1(-) 1.20% ± 0.11%; Ndi1(+) 1.46% ± 0.10%); expression of NDi1 in neurons improved hippocampal function, alleviated inhibition of presynaptic recycling, and increased ATP levels during isoflurane exposure. The clear alignment of cell culture data to in vivo phenotypes of both isoflurane-sensitive and -resistant mice indicates that inhibition of mitochondrial complex I is a primary mechanism of action of volatile anesthetics.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; complex I; endocytosis; exocytosis; mitochondria; mouse; presynapse; volatile anesthetics

Mesh:

Substances:

Year:  2022        PMID: 35688155      PMCID: PMC9329204          DOI: 10.1016/j.cub.2022.05.037

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.900


  68 in total

1.  Mitochondrial defects and anesthetic sensitivity.

Authors:  Phil G Morgan; Charles L Hoppel; Margaret M Sedensky
Journal:  Anesthesiology       Date:  2002-05       Impact factor: 7.892

2.  Naturally occurring variability in anesthetic potency among inbred mouse strains.

Authors:  J M Sonner; D Gong; E I Eger
Journal:  Anesth Analg       Date:  2000-09       Impact factor: 5.108

Review 3.  Glutathione, protein sulfhydryls and cysteine proteases in gastric mucosal injury and protection.

Authors:  S Szabo; L Nagy; M Plebani
Journal:  Clin Chim Acta       Date:  1992-03-13       Impact factor: 3.786

Review 4.  Molecular and cellular mechanisms of general anaesthesia.

Authors:  N P Franks; W R Lieb
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

5.  Glutamatergic Neurotransmission Links Sensitivity to Volatile Anesthetics with Mitochondrial Function.

Authors:  Pavel I Zimin; Christian B Woods; Albert Quintana; Jan-Marino Ramirez; Philip G Morgan; Margaret M Sedensky
Journal:  Curr Biol       Date:  2016-08-04       Impact factor: 10.834

6.  The effect of halothane on mitochondrial permeability to NADH.

Authors:  M L Nahrwold; J H Lecky; P J Cohen
Journal:  Life Sci       Date:  1974-10-01       Impact factor: 5.037

7.  Is depression of mitochondrial respiration a predictor of in-vivo anesthetic activity?

Authors:  M L Nahrwold; C R Clark; P J Cohen
Journal:  Anesthesiology       Date:  1974-06       Impact factor: 7.892

8.  mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

Authors:  Simon C Johnson; Melana E Yanos; Ernst-Bernhard Kayser; Albert Quintana; Maya Sangesland; Anthony Castanza; Lauren Uhde; Jessica Hui; Valerie Z Wall; Arni Gagnidze; Kelly Oh; Brian M Wasko; Fresnida J Ramos; Richard D Palmiter; Peter S Rabinovitch; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein
Journal:  Science       Date:  2013-11-14       Impact factor: 47.728

9.  Genetic variability affects absolute and relative potencies and kinetics of the anesthetics isoflurane and sevoflurane in Drosophila melanogaster.

Authors:  Zachariah P G Olufs; Carin A Loewen; Barry Ganetzky; David A Wassarman; Misha Perouansky
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

10.  Dynamic Variations in Brain Glycogen are Involved in Modulating Isoflurane Anesthesia in Mice.

Authors:  Ze Fan; Zhihao Zhang; Shiyi Zhao; Yuanyuan Zhu; Dong Guo; Bo Yang; Lixia Zhuo; Jiao Han; Rui Wang; Zongping Fang; Hailong Dong; Yan Li; Lize Xiong
Journal:  Neurosci Bull       Date:  2020-10-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.